There was an abundance of promising new research that came out of the 2023 San Antonio Breast Cancer Symposium. Here are some highlights for metastatic breast cancer. Be sure to check out our early-stage highlights.

CBCN had the pleasure of attending the San Antonio Breast Cancer Symposium in December. Below you’ll find the latest research for early-stage breast cancer. Watch out for the latest research on mBC.

CBCN had the opportunity to attend the ABC7 conference in Lisbon, Portugal from November 9 to 11, 2023. Here are some highlights from the conference.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held on October 3, 2023. In this session, Surgical Oncologist Dr. Mark Basik answers your questions about clinical trials. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

The European Society of Medical Oncology held their annual congress in Madrid, Spain from October 20-24, 2023. Members of the CBCN team had the opportunity to attend and learn about the latest research to be announced for breast cancer. Here are some of those highlights.

According to research from the National Cancer Institute, the number of women being diagnosed with metastatic breast cancer is increasing; at the same time, these women are living longer, especially younger women. Living longer with metastatic breast cancer, a stage of breast cancer which is driven in part by out-of-control production of proteins by cancerous cells, means increased needs for services and research.

The 2023 American Society of Clinical Oncology (ASCO) annual meeting was held from June 2 to 6. CBCN was pleased to be able to attend and participate in the many interesting and groundbreaking research that was shared at ASCO this year. Below, we present a few highlights and takeaways from this year’s conference.

The San Antonio Breast Cancer Symposium (SABCS) is the annual breast cancer conference that brings together researchers, clinicians, patients and manufacturers from all over the world to discuss the latest breast cancer research. Last December, we were pleased to be able to attend in-person, and we'd like to share with you the highlights from SABCS.

Have you ever found yourself confused and wondering what all those scientific terms mean in the research studies we share on breast cancer? If so, we’ve compiled a list of common terms used in various breast cancer news articles to help explain how they are used in determining the results and progress of clinical trials and research.

This year top researchers, physicians, manufacturers, and patient advocates met in-person and virtually for the annual San Antonio Breast Cancer Symposium. Once again, this conference shared an abundance of new research on breast cancer from around the globe.

A little more than two months ago, I started having weird pains in my right breast. It’s a throbbing sensation that radiates from the right side of my breast all the way to my nipple and then beneath my breast. Sometimes it happens when my arm leans into my breast, other times when I move my entire arm and once in a while, from the impact of my bra resting against my breast. Touching the area with my hands only intensifies the pain and since I seem to have zero impulse control, I find myself pressing into these spots all the time to check if the pain is still there. It is.

Breast cancer research is critical as it provides information on the detection, prognosis, treatment, and elimination of the disease. Researchers also continuously engage in studying breast cancer to help us better understand risks associated with breast cancer as well as how breast cancer interferes with other diseases and aspects of life.  

According to the World Health Organization (WHO), breast cancer is the most common form of cancer, with more than 2.2 million cases in 2020. It is estimated that 1 in 12 women will develop breast cancer and it will be the primary cause of death among all other types of cancer in women. However, breast cancer survival has improved significantly since the 1980s due to increased early detection, screening programs, and improved treatment options.

February 4^th is recognized as World Cancer Day, a global initiative led by the Union for International Cancer Control (UICC) that is focused on awareness, education and action. The goal of this day is to create a world where death from cancer is preventable and where everyone can access proper care and life-saving treatment.

2020 was eventful, to say the least. It was a year where many had to shift and pivot from their everyday normal. Appointments were cancelled, surgeries were delayed and rescheduled, and patients found themselves having to access their doctors and healthcare team through a screen. Breast cancer patients had to not only worry about their risk of contracting the COVID-19 virus, but they also had to maintain their cancer care as best they could, something that was a challenge both mentally and physically.

I’m a talker. I like to communicate and sometimes, okay often, I’m an over-sharer. I need to know what’s going on and why and in my version of yin and yang, I believe that because I’m an open book everyone else will be too. Except, not so much.

Before I was diagnosed, I rarely thought about breast cancer. When I did it was once a year, usually in June, as I was planning the line-up of pink-ribbon beauty products I wanted to feature in the upcoming October issue of FASHION, Salon, 29Secrets or whatever other magazine I was working for at the time. Other than that, it just wasn’t on my radar. No disease was really. My inner circle was healthy, well, that is if you didn’t count my mom’s dad dying of liver sclerosis from alcoholism when I was around five or my paternal grandmother passing from Alzheimer’s when I was in my early thirties.

Sugar, in all its stark white, sparkling glory is an enormously popular, widely misunderstood, and a hotly debated topic in the breast cancer world. Rarely a week passes when I don’t hear or read “Sugar feeds breast cancer”, proclaimed with absolute certainty. People accept this declaration as truth, yet I ask; does it really?

In part 1 of our clinical trials series, we explained that clinical trials allow doctors and researchers to test treatments, medical procedures and therapies for various diseases and conditions. In the second part of the series, we debunked 7 common myths on clinical trials. In both parts, we focused on the type of clinical trials most people think of when they hear clinical trials, studies involving drugs. However, clinical trials can study more than just drug treatments or surgeries. According to Clinical Trials Ontario, they can also be conducted to “test devices, genetic therapies, natural health products, psychotherapies, lifestyle and preventive care interventions, and many other things.”

Two years ago, I had the sincere pleasure of attending my first oncology nutrition symposium, a biennial event hosted by the Oncology Dietetic Practice Group of the Academy of Nutrition and Dietetics. Nutrition science ruled at this event, and “voodoo nutrition” based on conjecture, personal opinion, philosophies, and miracle cures was denied a seat at the table.